Prevention and treatment of anticipatory chemotherapy-induced nausea and vomiting in pediatric cancer patients and hematopoietic stem cell recipients: Clinical practice guideline update

Priya Patel; Paula D. Robinson; Katie A. Devine; Karyn Positano; Marie Cohen; Paul Gibson; Mark Holdsworth; Robert Phillips; Daniela Spinelli; Jennifer Thackray; Marianne van de Wetering; Deborah Woods; Sandra Cabral; Lillian Sung; L. Lee Dupuis

doi:10.1002/pbc.28947

Prevention and treatment of anticipatory chemotherapy-induced nausea and vomiting in pediatric cancer patients and hematopoietic stem cell recipients: Clinical practice guideline update

Priya Patel, Paula D. Robinson, Katie A. Devine, Karyn Positano, Marie Cohen, Paul Gibson, Mark Holdsworth, Robert Phillips, Daniela Spinelli, Jennifer Thackray, Marianne van de Wetering, Deborah Woods, Sandra Cabral, Lillian Sung, L. Lee Dupuis

Research related

Research output: Contribution to journal › Article › peer-review

18 Citations (Scopus)

Abstract

This 2021 clinical practice guideline update provides recommendations for preventing anticipatory chemotherapy-induced nausea and vomiting (CINV) in pediatric patients. Recommendations are based on systematic reviews that identified (1) if a history of acute or delayed CINV is a risk factor for anticipatory CINV, and (2) interventions for anticipatory CINV prevention and treatment. A strong recommendation to optimize acute and delayed CINV control in order to prevent anticipatory CINV is made. Conditional recommendations are made for hypnosis, systematic desensitization, relaxation techniques, and lorazepam for the secondary prevention of anticipatory CINV. No recommendation for the treatment of anticipatory CINV can be made.

Original language	English
Article number	e28947
Journal	Pediatric Blood and Cancer
Volume	68
Issue number	5
DOIs	https://doi.org/10.1002/pbc.28947
Publication status	Published - May 2021

Keywords

anticipatory
chemotherapy-induced nausea and vomiting
pediatric oncology
supportive care

Access to Document

10.1002/pbc.28947

Cite this

Patel, P., Robinson, P. D., Devine, K. A., Positano, K., Cohen, M., Gibson, P., Holdsworth, M., Phillips, R., Spinelli, D., Thackray, J., van de Wetering, M., Woods, D., Cabral, S., Sung, L., & Dupuis, L. L. (2021). Prevention and treatment of anticipatory chemotherapy-induced nausea and vomiting in pediatric cancer patients and hematopoietic stem cell recipients: Clinical practice guideline update. Pediatric Blood and Cancer, 68(5), Article e28947. https://doi.org/10.1002/pbc.28947

@article{6b6360dc47404c4fbf2f83cf222a1223,

title = "Prevention and treatment of anticipatory chemotherapy-induced nausea and vomiting in pediatric cancer patients and hematopoietic stem cell recipients: Clinical practice guideline update",

abstract = "This 2021 clinical practice guideline update provides recommendations for preventing anticipatory chemotherapy-induced nausea and vomiting (CINV) in pediatric patients. Recommendations are based on systematic reviews that identified (1) if a history of acute or delayed CINV is a risk factor for anticipatory CINV, and (2) interventions for anticipatory CINV prevention and treatment. A strong recommendation to optimize acute and delayed CINV control in order to prevent anticipatory CINV is made. Conditional recommendations are made for hypnosis, systematic desensitization, relaxation techniques, and lorazepam for the secondary prevention of anticipatory CINV. No recommendation for the treatment of anticipatory CINV can be made.",

keywords = "anticipatory, chemotherapy-induced nausea and vomiting, pediatric oncology, supportive care",

author = "Priya Patel and Robinson, {Paula D.} and Devine, {Katie A.} and Karyn Positano and Marie Cohen and Paul Gibson and Mark Holdsworth and Robert Phillips and Daniela Spinelli and Jennifer Thackray and {van de Wetering}, Marianne and Deborah Woods and Sandra Cabral and Lillian Sung and Dupuis, {L. Lee}",

note = "Publisher Copyright: {\textcopyright} 2021 Wiley Periodicals LLC",

year = "2021",

month = may,

doi = "10.1002/pbc.28947",

language = "English",

volume = "68",

journal = "Pediatric Blood and Cancer",

issn = "1545-5009",

publisher = "Wiley-Liss Inc.",

number = "5",

}

Patel, P, Robinson, PD, Devine, KA, Positano, K, Cohen, M, Gibson, P, Holdsworth, M, Phillips, R, Spinelli, D, Thackray, J, van de Wetering, M, Woods, D, Cabral, S, Sung, L & Dupuis, LL 2021, 'Prevention and treatment of anticipatory chemotherapy-induced nausea and vomiting in pediatric cancer patients and hematopoietic stem cell recipients: Clinical practice guideline update', Pediatric Blood and Cancer, vol. 68, no. 5, e28947. https://doi.org/10.1002/pbc.28947

Prevention and treatment of anticipatory chemotherapy-induced nausea and vomiting in pediatric cancer patients and hematopoietic stem cell recipients: Clinical practice guideline update. / Patel, Priya; Robinson, Paula D.; Devine, Katie A. et al.
In: Pediatric Blood and Cancer, Vol. 68, No. 5, e28947, 05.2021.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Prevention and treatment of anticipatory chemotherapy-induced nausea and vomiting in pediatric cancer patients and hematopoietic stem cell recipients

T2 - Clinical practice guideline update

AU - Patel, Priya

AU - Robinson, Paula D.

AU - Devine, Katie A.

AU - Positano, Karyn

AU - Cohen, Marie

AU - Gibson, Paul

AU - Holdsworth, Mark

AU - Phillips, Robert

AU - Spinelli, Daniela

AU - Thackray, Jennifer

AU - van de Wetering, Marianne

AU - Woods, Deborah

AU - Cabral, Sandra

AU - Sung, Lillian

AU - Dupuis, L. Lee

PY - 2021/5

Y1 - 2021/5

N2 - This 2021 clinical practice guideline update provides recommendations for preventing anticipatory chemotherapy-induced nausea and vomiting (CINV) in pediatric patients. Recommendations are based on systematic reviews that identified (1) if a history of acute or delayed CINV is a risk factor for anticipatory CINV, and (2) interventions for anticipatory CINV prevention and treatment. A strong recommendation to optimize acute and delayed CINV control in order to prevent anticipatory CINV is made. Conditional recommendations are made for hypnosis, systematic desensitization, relaxation techniques, and lorazepam for the secondary prevention of anticipatory CINV. No recommendation for the treatment of anticipatory CINV can be made.

AB - This 2021 clinical practice guideline update provides recommendations for preventing anticipatory chemotherapy-induced nausea and vomiting (CINV) in pediatric patients. Recommendations are based on systematic reviews that identified (1) if a history of acute or delayed CINV is a risk factor for anticipatory CINV, and (2) interventions for anticipatory CINV prevention and treatment. A strong recommendation to optimize acute and delayed CINV control in order to prevent anticipatory CINV is made. Conditional recommendations are made for hypnosis, systematic desensitization, relaxation techniques, and lorazepam for the secondary prevention of anticipatory CINV. No recommendation for the treatment of anticipatory CINV can be made.

KW - anticipatory

KW - chemotherapy-induced nausea and vomiting

KW - pediatric oncology

KW - supportive care

UR - http://www.scopus.com/inward/record.url?scp=85103035393&partnerID=8YFLogxK

U2 - 10.1002/pbc.28947

DO - 10.1002/pbc.28947

M3 - Article

C2 - 33686754

AN - SCOPUS:85103035393

SN - 1545-5009

VL - 68

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

IS - 5

M1 - e28947

ER -

Prevention and treatment of anticipatory chemotherapy-induced nausea and vomiting in pediatric cancer patients and hematopoietic stem cell recipients: Clinical practice guideline update

Abstract

Keywords

Access to Document

Fingerprint

Cite this